Jiangsu Hengrui Medicine
600276.SS
#460
Rank
NZ$75.38 B
Marketcap
$11.82
Share price
-0.54%
Change (1 day)
8.31%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Cash on Hand

Cash on Hand as of September 2024 : NZ$5.56 Billion

According to Jiangsu Hengrui Medicine 's latest financial reports the company has NZ$5.56 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Jiangsu Hengrui Medicine - Cash on Hand chart (from 2000 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31NZ$4.08 B-5.12%
2021-12-31NZ$4.30 B23.18%
2020-12-31NZ$3.49 B21.12%
2019-12-31NZ$2.88 B19.17%
2018-12-31NZ$2.41 B161.94%
2017-12-31NZ$0.92 B-9.57%
2016-12-31NZ$1.02 B-11.75%
2015-12-31NZ$1.15 B62.78%
2014-12-31NZ$0.71 B62.99%
2013-12-31NZ$0.43 B68.27%
2012-12-31NZ$0.25 B33.92%
2011-12-31NZ$0.19 B-0.77%
2010-12-31NZ$0.19 B36.83%
2009-12-31NZ$0.14 B21.16%
2008-12-31NZ$0.11 B-22.08%
2007-12-31NZ$0.15 B44.03%
2006-12-31NZ$0.10 B34%
2005-12-31NZ$78.23 M26.96%
2004-12-31NZ$61.62 M64.68%
2003-12-31NZ$37.41 M-15.31%
2002-12-31NZ$44.18 M-43.96%
2001-12-31NZ$78.84 M-40.2%
2000-12-31NZ$0.13 B480.88%
1999-12-31NZ$22.69 M249.59%
1998-12-31NZ$6.49 M19.66%
1997-12-31NZ$5.42 M